Market Tracker

03/23 5:16pm ET

Navidea Biopharmaceuticals Inc (NYSE MKT LLC:NAVB)

0.57
Delayed Data
As of 4:02pm ET
 -0.0299 / -4.98%
Today’s Change
0.26
Today|||52-Week Range
1.51
-10.59%
Year-to-Date
No recent news for Navidea Biopharmaceuticals Inc.

Today’s Trading

Previous close0.60
Today’s open0.59
Day’s range0.56 - 0.63
Volume531,254
Average volume (3 months)1,092,799
Market cap$93.4M
Dividend yield--
Data as of 4:02pm ET, 03/23/2017

Growth & Valuation

Earnings growth (last year)+25.00%
Earnings growth (this year)+55.56%
Earnings growth (next 5 years)--
Revenue growth (last year)+111.15%
P/E ratioNM
Price/Sales15.18
Price/Book--

Competitors

 Today’s
change
Today’s
% change
ALIMAlimera Sciences Inc0.000.00%
ECYTEndocyte Inc+0.04+1.81%
ADMPAdamis Pharmaceutica...-0.25-5.62%
EPIXESSA Pharma Inc-0.17-5.18%
Data as of 3:59pm ET, 03/23/2017

Financials

Last reporting dateMarch 23, 2017
EPS forecast (this quarter)-$0.01
Annual revenue (last year)$13.2M
Annual profit (last year)-$27.6M
Net profit margin-213.76%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Mike M. Goldberg
Chief Operating &
Financial Officer
Jed Andrew Latkin
Corporate headquarters
Dublin, Ohio

Forecasts